Arriving in the landscape of weight management treatment, retatrutide represents a distinct approach. Different from many existing medications, retatrutide works as a twin agonist, at once affecting both GLP-like peptide-1 (GLP-1) and glucose-responsive insulinotropic hormone (GIP) sensors. This dual stimulation promotes multiple beneficial effects… Read More